Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jan 1;69(1):7-11.
doi: 10.1016/j.biopsych.2010.07.004. Epub 2010 Aug 21.

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

Affiliations
Clinical Trial

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

Jason R Tregellas et al. Biol Psychiatry. .

Abstract

Background: 3-(2,4-dimethoxybenzylidene)-anabaseine (DMXB-A) is a partial agonist at α7 nicotinic acetylcholine receptors that has been evaluated clinically for treatment of schizophrenia. This study examined the effects of DMXB-A on default network activity as a biomarker for drug effects on pathologic brain function associated with schizophrenia.

Methods: Placebo and two doses of DMXB-A were administered in a random, double-blind crossover design during a Phase 2 study of DMXB-A. Functional magnetic resonance imaging was performed on 16 nonsmoking patients with schizophrenia while they performed a simple eye movement task. Independent component analysis was used to identify the default network component. Default network changes were evaluated in the context of a polymorphism in CHRNA7, the α7-nicotinic acetylcholine receptor subunit gene, which was previously found to be associated with schizophrenia.

Results: Compared with placebo, both 150 and 75 mg twice daily DMXB-A altered default network activity, including a reduction in posterior cingulate, inferior parietal cortex, and medial frontal gyrus activity and an increase in precuneus activity. The most robust difference, posterior cingulate activity reduction, was affected by CHRNA7 genotype.

Conclusions: The observed DMXB-A-related changes are consistent with improved default network function in schizophrenia. Pharmacogenetic analysis indicates mediation of the effect through the α7-nicotinic receptor. These results further implicate nicotinic cholinergic dysfunction in the disease and suggest that default network activity may be a useful indicator of biological effects of novel therapeutic agents.

Trial registration: ClinicalTrials.gov NCT00100165.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of DMXB-A on default network activity. Left panels indicate regions that showed reduced activity following administration of drug (collapsed across drug dose), compared to placebo administration. Right panels show areas of greater activity. Statistical maps thresholded at p < 0.05, FWE corrected. Data are shown in the radiological convention (R on L). Individual subject responses are shown in bottom panels.
Figure 2
Figure 2
Effects of DMXB-A dose and CHRNA7 genotype (SNP rs3087454) on default network activity in 16 patients with schizophrenia. Most common allele indicates homozygosity for this genotype.
Figure 3
Figure 3
Relationship between difference in BPRS (left) and SANS (right) scores and difference in default network activity from placebo to DMXB-A (collapsed across dose).

Comment in

Similar articles

Cited by

References

    1. Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. BiolPsychiatry. 1995;38:22–33. - PubMed
    1. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. ProcNatlAcadSciUSA. 1997;94:587–592. - PMC - PubMed
    1. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. ArchGenPsychiatry. 2002;59:1085–1096. - PubMed
    1. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. AmJPsychiatry. 1986;143:993–997. - PubMed
    1. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. AmJPsychiatry. 1995;152:453–455. - PubMed

Publication types

MeSH terms

Associated data